YK-11
Also known as: YK11, Myostine
Classification
Sarm
Regulatory Status
not-established
Sources
3
Review
n/a
Overview
YK-11 is described as a steroidal partial agonist of the androgen receptor with preclinical reports of myostatin-related gene effects; it is not an approved drug and human pharmacology is poorly characterized.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pathways
Interactions & cautions
Flagged in source data
testosterone or anabolic steroids without review
Drug interactions
androgens or anabolic steroids — Additive suppression and hepatotoxicity concerns possible (review)
hepatotoxic agents — May increase DILI risk (review)
These are observational flags for review, not individualized instructions.
Sources
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw